Processa pharmaceuticals to present at the sidoti & co. micro cap virtual conference

Hanover, md, aug. 10, 2023 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa) (“processa” or the “company”), a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that david young, president of research and development, will present a corporate overview at the sidoti & co. micro cap virtual conference being held on august 16 – 17, 2023.
PCSA Ratings Summary
PCSA Quant Ranking